Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 11,627 | 8,895 | 8,801 | 5,927 | 0 |
| Operating Income | -11,627 | -8,895 | -8,801 | -5,927 | N/A |
| Other Income | -7 | 57 | -51 | 0 | 0 |
| Pre-tax Income | -11,634 | -8,838 | -8,852 | -5,927 | 0 |
| Net Income Continuous | -11,634 | -8,838 | -8,852 | -5,927 | N/A |
| Net Income | $-11,634 | $-8,838 | $-8,852 | $-5,927 | $N/A |
| EPS Basic Total Ops | 68.53 | -28.33 | -28.53 | -20.62 | N/A |
| EPS Basic Continuous Ops | 48.26 | -20.04 | -20.23 | -14.82 | N/A |
| EPS Diluted Total Ops | 68.53 | -28.33 | -28.53 | -20.62 | N/A |
| EPS Diluted Continuous Ops | 48.26 | -20.04 | -20.23 | -14.82 | N/A |
| EBITDA(a) | $-11,397 | $-8,679 | $-8,601 | $-5,742 | $N/A |